JANE STREET GROUP, LLC

Position in FATE — Fate Therapeutics Inc

CIK 1595888 NEW YORK, NY

Back to FATE Full portfolio

Position in FATE

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$776,373

-$49,576 QoQ

Shares Held

646,979

-23.2% QoQ

Ownership

0.555%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Derivatives in FATE

reported options exposure · as of Mar 31, 2026

CallValue

$17,520

CallShares

14,600

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. FATE ranks #131 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,757,672	$130,524,721
2	RPRX	Royalty Pharma plc	2,400,382	$115,146,324
3	TGTX	Tg Therapeutics, Inc.	2,041,669	$67,824,242
4	VRTX	Vertex Pharmaceuticals Inc / Ma	122,946	$54,900,305
5	HALO	Halozyme Therapeutics, Inc.	831,707	$53,753,223
6	EXEL	Exelixis, Inc.	1,087,030	$46,622,715
7	JAZZ	Jazz Pharmaceuticals plc	223,615	$42,274,415
8	BNTX	BioNTech SE	336,757	$29,930,962

All Filings in FATE

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,520	14,600	-97.7%	Call	Defined	2026-05-12
2026-03-31	$776,373	646,979	-23.2%	Shares	Defined	2026-05-12
2025-12-31	$825,949	842,807	+6484.4%	Shares	Defined	2026-02-12
2025-09-30	$16,128	12,800	-97.9%	Call	Defined	2025-11-14
2025-09-30	$760,738	603,761	+29.6%	Shares	Defined	2025-11-14
2025-06-30	$521,717	465,820	+631.4%	Shares	Defined	2025-08-14
2025-03-31	$50,315	63,691	+106.9%	Shares	Defined	2025-05-19
2024-12-31	$50,786	30,780	-79.2%	Shares	Defined	2025-02-14
2024-09-30	$517,552	147,872	-32.1%	Shares	Defined	2024-11-15
2024-06-30	$714,183	217,739	+11.9%	Shares	Defined	2024-08-15
2024-03-31	$1,428,796	194,659	-72.6%	Shares	Defined	2024-05-16
2023-12-31	$2,660,212	711,287	-1.8%	Shares	Defined	2024-02-15
2023-09-30	$1,535,458	724,273	+57.4%	Shares	Defined	2023-11-15
2023-06-30	$2,190,942	460,282	+384.4%	Shares	Defined	2023-08-14
2023-03-31	$541,659	95,028	-38.7%	Shares	Defined	2023-05-16
2022-12-31	$1,563,414	154,947	+1199.5%	Shares	Defined	2023-02-15
2022-09-30	$267,216	11,924	-46.3%	Shares	Defined	2022-11-15
2022-06-30	$549,992	22,195	+52.0%	Shares	Defined	2022-08-16
2022-03-31	$566,042	14,600	-29.1%	Put	Defined	2022-05-17
2022-03-31	$798,662	20,600	-72.8%	Call	Defined	2022-05-17
2021-12-31	$4,435,058	75,800	+938.4%	Call	Defined	2022-02-15
2021-12-31	$427,123	7,300	-71.1%	Put	Defined	2022-02-15
2021-12-31	$1,476,499	25,235	+62.1%	Shares	Defined	2022-02-15
2021-09-30	$922,478	15,564	+85.3%	Shares	Defined	2021-11-16
2021-09-30	$497,868	8,400	+18.3%	Put	Defined	2021-11-16
2021-09-30	$420,817	7,100	-56.9%	Call	Defined	2021-11-16
2021-06-30	$1,429,951	16,476	+63.1%	Shares	Defined	2021-08-16
2021-06-30	$876,579	10,100	+62.9%	Put	Defined	2021-08-16
2021-06-30	$538,098	6,200	-48.3%	Call	Defined	2021-08-16
2021-03-31	$989,400	12,000	+207.7%	Call	Defined	2021-05-18
2021-03-31	$321,555	3,900	-90.6%	Put	Defined	2021-05-18
2021-03-31	$3,403,040	41,274	-35.0%	Shares	Defined	2021-05-18
2020-12-31	$5,772,962	63,488	+1823.9%	Shares	Defined	2021-02-17
2020-12-31	$300,069	3,300	-92.4%	Call	Defined	2021-02-17
2020-09-30	$1,741,692	43,575	+445.9%	Shares	Defined	2020-11-17
2020-06-30	$273,861	7,982	-10.3%	Shares	Defined	2020-08-17
2020-06-30	$305,359	8,900	-19.6%	Call	Defined	2020-08-17
2020-03-31	$245,886	11,071	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.